Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence
US Patent 8,217,222
Filed on 2006-09-29
Filed on 2006-09-29
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Sweden
04011673.3
Filed on 1998-09-22
04011673.3
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Portugal
04011673.3
Filed on 1998-09-22
04011673.3
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Italy
04011673.3
Filed on 1998-09-22
04011673.3
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Ireland
04011673.3
Filed on 1998-09-22
04011673.3
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Greece
04011673.3
Filed on 1998-09-22
04011673.3
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Finland
04011673.3
Filed on 1998-09-22
04011673.3
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Spain
04011673.3
Filed on 1998-09-22
04011673.3
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Cyprus
04011673.3
Filed on 1998-09-22
04011673.3
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Switzerland
04011673.3
Filed on 1998-09-22
04011673.3
Filed on 1998-09-22